$30K Awards Available for Lung Cancer Research

Lung Cancer grant logo

Applications for the Vicky Amidon Innovation Grant in Lung Cancer Research Award are due Oct. 1.

The one-year grant, for up to $30,000, is offered by the Lung Cancer Initiative of North Carolina. The group is looking to fund two innovative projects centered on lung cancer prevention, diagnosis, treatment, or survivorship. Undertakings intent on lung cancer research, awareness, education or access programs are eligible for the grant. Submissions which will seek matching or additional funding for project completion are also eligible.

Researchers of all levels and at all institutions and companies across North Carolina are encouraged to apply.

2019 inaugural award recipient

The inaugural award recipient was Andrew Bishop, Ph.D., of the Wake Forest School of Medicine. His project is focused on developing a breath test to be used as a non-invasive form of lung cancer screening. “Detecting lung cancer signatures in exhaled breath would greatly impact a clinician’s ability to detect cancer earlier and with minimally invasive tests, thereby impacting patient treatment and outcomes,” says Bishop.

Award notification information

LCI will notify all applicants about the winning projects on November 1. Projects will begin at the start of 2020, and the selected applicants will provide a progress report at a Lung Cancer Initiative meeting within a year of project completion.

LCI is North Carolina’s leading non-profit exclusively targeting lung cancer research and education.

Any questions regarding the submission process should be emailed to Jenni Danai, MPH at JDanai@LungCancerInitiativeNC.org

Lindsey Baron, NCBiotech Writer
Grifols tour
Grifols celebrates 50 years in Clayton

Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC.

Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Grifols into a top-three plasma-sector powerhouse. 

Read more »
FDB aerial
FUJIFILM Diosynth Biotechnologies to double Holly Springs biomanufacturing campus

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs.

When completed, the site will be the largest end-to-end cell culture CDMO facility in North America, housing state-of-the-art biopharmaceutical manufacturing equipment and technology, including two large manufacturing suites for large-scale monoclonal antibody drug substance and drug product manufacturing. 

Read more »
Cell CEO Pace
Single-cell solution: How Cell Microsystems wants to help scientists speed therapeutic breakthroughs

Gary Pace, PhD, remembers precisely when he realized that Cell Microsystems had to change. It was 2014, and Pace had recently signed on as CEO of the UNC-Chapel Hill spinout company. He sat in a meeting listening to feedback from potential customers. “We had convened a group of academic scientists talking about what they need. Have they tried our product? Where can we take it?” he recalled. “It was at that meeting that I realized that we couldn’t take a technology perspective on the product.

Read more »
scroll back to top of page